From: Tissue dyslipidemia in salmonella-infected rats treated with amoxillin and pefloxacin
Plasma | Normal control | Infection control | Infected+ pefloxacin day 5 | Infected+ pefloxacin day 10 | Infected + pefloxacin day 15 | Infected+ amoxillin day 5 | Infected+ amoxillin day 10 | Infected + amoxillin day 15 |
---|---|---|---|---|---|---|---|---|
Cholesterol (mg/dl) | 56.60±2.43a | 104.13±6.60b | 79.14±5.49c | 79.04±5.84c | 77.96±5.73c | 59.86±7.54d | 73.55±7.05c | 69.16±6.70d |
Triacylglycerols (mg/dl) | 63.18±5.19a | 125.18±14.26c | 77.32±0.99b | 97.48±10.89c | 58.43±5.89a | 112.78±6.78d | 127.58±17.61d | 68.16±3.72b |
Phospholipid (mg/dl) | 75.33±15.41a | 129.60±23.13c | 122.96±7.93c | 100.60±15.55b | 109.84±10.18b | 130.25±18.29c | 109.35±10.40b | 66.10±20.74a |
Free Fatty acid (mg/dl) | 14.10±2.25a | 23.08±0.75c | 17.20±0.39b | 16.50±1.23b | 17.28±0.55b | 17.70±1.18b | 16.16±0.53b | 18.87±0.74b |
HDL | ||||||||
Cholesterol (mg/dl) | 39.06±2.77b | 22.19±0.94a | 21.08±4.03a | 37.19±8.41b | 21.16±1.39a | 18.06±5.97a | 36.76±2.74b | 22.36±1.75a |
Triacylglycerols (mg/dl) | 26.83±3.65a | 37.75±7.17a | 25.12±3.63a | 33.98±3.43a | 25.81±2.29a | 28.26±5.51a | 27.28±4.08a | 39.50±4.14a |
Phospholipid (mg/dl) | 68.53±1.42a | 29.57±1.71b | 89.91±19.50e | 73.87±12.24d | 52.49±7.31c | 71.93±7.31d | 66.10±14.67d | 48.60±7.37c |
LDL-VLDL | ||||||||
Cholesterol (mg/dl) | 25.94±2.31b | 49.03±2.39e | 15.24±2.32a | 43.38±3.75e | 36.17±3.23d | 28.64±3.34c | 43.38±3.00e | 34.33±3.80d |
Triacylglycerols (mg/dl) | 22.43±1.72a | 68.66±4.26d | 24.02±1.40a | 56.50±8.71c | 36.90±1.58b | 28.61±2.78a | 49.05±3.57c | 58.37±7.38d |
Phospholipid (mg/dl) | 86.99±2.81a | 95.18±5.63c | 64.64±4.04b | 110.81±2.73c | 107.41±2.14c | 69.50±4.18b | 117.13±9.23d | 83.11±4.31a |